Head-To-Head Comparison Of Obinutuzumab (Ga101) Plus Chlorambucil (Clb) Versus Rituximab Plus Clb In Patients With Chronic Lymphocytic Leukemia (Cll) And Co-Existing Medical Conditions (Comorbidities): Final Stage 2 Results Of The Cll11 Trial